Neogenomics creates software

FORT MYERS — Cancer testing firm Neogenomics says it has developed software that will help it automate the reading and interpretation of cancer tests.

The Fort Myers-based company says it has applied for a patent for the software and will consider licensing it to other cancer-testing providers.

Currently, employees conduct certain cancer tests manually, and most laboratories only count 50 cells. The new software will automate that process and is more accurate because it can count more cells. This is important for lung-cancer patients, for instance, who require tailored therapy for successful treatment, the company says.